Policy and Advocacy Library
The library is the culmination of the collaborative work of RACP members and comprises a comprehensive range of evidence-based, published RACP position statements, policies and submissions.
To contribute your expertise, go to represent your profession.
Contact us if you can’t find what you’re looking for.
Search results
Description
The RACP welcomes the development of Disability Foundational (General) Supports to complement the NDIS and mainstream services, aiming to empower people with disability, their families, and carers through capacity-building, inclusion, and advocacy.
Description
This RACP submission to Manatū Hauora | Ministry of Health’ supports the exploration of ‘active ageing’ as a critical topic for a Long-term Insights Briefing to provide information about medium and long-term trends, risks and opportunities that may affect Aotearoa New Zealand.
Description
This RACP Position Statement provides the rationale and evidence for a health-focused approach to guide policy development by governments and organisations in Australia and Aotearoa New Zealand. It aims to support governments at all levels in developing a comprehensive, all-of-government response to illicit drug issues, covering education, prevention, treatment, and harm reduction strategies that are effective, ethical, empowering, and evidence-based.
Topic
RACP recommendations
Description
This RACP submission outlines the College’s feedback to the Department of Health and Aged Care on the draft National Roadmap to Improve the Health and Mental Health of Autistic People. The draft Roadmap aims to address the serious health inequities faced by autistic people in Australia.
Topic
RACP recommendations
Description
This RACP Submission to the Parliamentary Inquiry into the health impacts of alcohol and other drugs in Australia to the House Standing Committee on Health, Aged Care and Sport has been led by the RACP’s Australasian Chapter of Addiction Medicine (AChAM) in consultation with relevant committees and affiliated specialty societies. It stresses the crucial importance of prioritising a health approach to alcohol and other drug use to effectively reduce harms for those who use drugs, their families and the broader community.
Topic
RACP recommendations
Description
The submission lead by the RACP’s Māori Health Committee provides feedback on the proposed direction of development of the Hauora Māori Strategy 2025. The RACP strongly supports ensuring that the Aotearoa health system honours the principles of te Tiriti o Waitangi in the way it is managed and operated, is pro-equity, and enhances long-term health outcomes for whānau Māori.
Topic
RACP recommendations
Description
The RACP submission to the Senate Committee on youth justice emphasises the need for a health-first approach to reforming Australia’s youth justice and incarceration system, alongside prioritising First Nations leadership.
Topic
RACP recommendations
Description
This submission provides input into the Tasmanian House of Assembly Government Administration Committee B’s inquiry into the assessment and treatment of ADHD and support services. The submission focuses on access to ADHD diagnosis, access to supports following assessment, workforce availability and training, ongoing management of patients with ADHD, and regulations regarding access to ADHD medications. The submission is based on member feedback and existing College positions.
Topic
RACP recommendations
Description
This RACP submission to the Medical Board of Australia’s consultation on health checks for late career doctors responded to the Board’s proposal to introduce health checks for medical practitioners over the age of 70. It urges the Board to balance its proposal to introduce health checks with adverse impacts on medical workforce supply, demand and patient access to care. It also encourages the Board to engage further with the RACP, its faculties, chapters and specialty societies on fit-for-purpose, tailored and appropriate health check approaches for specific physician and specialist scopes of practice.
Topic
RACP recommendations
Description
The RACP submitted to Pharmac to support its proposal to remove the renewal criteria for stimulants methylphenidate, dexamfetamine and modafinil from 1 December 2024. This proposal has the potential to remove barriers to ongoing treatment and management of ADHD and narcolepsy in terms of costs and waiting times and may relieve workforce pressures.
